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1. INTRODUCTION 
 
1.1. Stroke  
1.1.1. Definition of cerebral stroke 
Stroke is a clinical syndrome, and has been defined by the World Health 
Organization (WHO) as “rapidly developing clinical signs of focal (at times 
global) disturbance of cerebral function, lasting more than 24 hours or leading to 
death with no apparent cause other than that of vascular origin”(1). A stroke is 
caused by the interruption of the blood supply to the brain, causing damage to the 
brain tissue. Transient ischaemic attack (TIA) is traditionally defined as “an 
episode of temporary and focal cerebral dysfunction of vascular origin, rapid in 
onset, which is variable in duration, commonly lasting from 2 to 15 minutes but 
occasionally lasting as long as 24 hours. The attack leaves no persistent 
neurological deficit” (2). The increasing use of diffusion weighted imaging has 
revealed cerebral infarction in patients with transient symptoms (3), and a new 
definition of TIA has been suggested (4). The new definition includes the absence 
of infarction: “a transient episode of neurological dysfunction, caused by focal 
brain, spinal cord or retinal ischemia, without acute infarction”. As a result of this, 
an ischaemic stroke is defined as an infarction of central nervous system tissue (4). 
In this definition, a stroke may be either symptomatic or silent. 
Ischaemic stroke accounts for about 80 % of all stroke cases, whereas primary 
intracerebral haemorrhage (about 15%) and subarachnoid haemorrhage explain the 
rest (5). This thesis will only deal with ischaemic stroke. 
Ischaemic stroke is caused by occlusion of an artery, either by an embolus or a 
thrombus. The reduction of cerebral blood flow leads to an infarct core of 
irreversibly damaged cells with a surrounding penumbra. In the penumbral zone 
there is constrained blood supply with intermittently comprised energy 
metabolism, which leads to dysfunctional neurons (6-8). If reperfusion can be 
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achieved within a short time, the neurological deficits caused by the penumbra 
may be reversed. 
 
1.1.2. Epidemiology 
Stroke is a common disorder, and one of the leading causes of death worldwide 
and disability in the western countries (5, 9, 10). The age-standardised stroke 
incidence rate worldwide in 2010 was 258 per 100 000 person-years, 
corresponding to 16.9 million people with first stroke (11). In the same study, the 
stroke incidence rate was 217 per 100 000 person-years in high-income countries. 
In a study from 2009 (12), the stroke incidence rates in Europe were 141 per 
100 000 in men and 94.6 per 100 000 in women. There were considerable 
variations between the European regions. In Norway, the estimated number of 
strokes per year is about 14500 (13).  
 
Figure 1. Deaths by stroke in Norway (1969-2012) 
Adapted from Statistics Norway (14) 
 
The stroke incidence and mortality rate have decreased the last decades in high-
income countries, probably due to better stroke risk factor control (11, 15). The 
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converse has been shown for low- and middle-income countries. The prevalence of 
stroke is higher in high-income countries compared to low- and middle-income 
countries, due to an inverse association between prevalence of stroke and stroke 
mortality. The incidence rate increases by age, and because of an ageing 
population, the burden of stroke in high-income countries will increase (15). Even 
though the incidence of stroke in high-income countries is decreasing, the overall 
global burden of stroke is increasing (11). 
 
Figure 2. Stroke incidence in Norway (patients 65 years of age or older) 
Adapted from Scenario 2030, Norwegian Board of Health Supervision (June 1999) (16) 
  
1.1.3. Stroke diagnosis 
Stroke is a clinical diagnosis. It is typically characterised by acute onset of focal 
symptoms like hemiparesis, sensory loss, facial paresis and dysarthria. The 
symptoms may vary, and depend on the localisation of the lesion. Cortical lesions 
may lead to aphasia, apraxia, homonymous hemianopia and neglect, while 
cerebellar lesions may cause ataxia. The symptoms might be more diffuse like 
confusion, unsteadiness or loss of balance, which can make diagnosing stroke 
challenging. Thorough clinical history and neurological examination are required 
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for diagnosing stroke. The patients should be admitted to a Stroke Unit (SU), and 
undergo standard examination including blood samples, electrocardiogram (ECG) 
records and cerebral computed tomography (CT) at admission. Further 
examination should be performed during the stay to identify the underlying cause 
of stroke (17-19).  
There are several clinical assessments used in monitoring neurological deficits and 
outcome after stroke, but the reliability of these instruments vary (20). National 
Institutes of Health Stroke Scale (NIHSS) (21, 22) and the Scandinavian Stroke 
Scale (SSS) (23) are frequently used in SUs and large clinical trials. NIHSS is 
useful in monitoring acute status, effect of treatment and outcome (24). Bartel 
Index (BI) (25) of activities of daily living and modified Rankin Scale (mRS) (26, 
27) are functional scales, i.e. refer to the capacity to perform a task.  
There is a lack of standardised tools for testing cognitive function after stroke. 
Cognitive assessments in the acute phase of stroke can be used to detect cognitive 
deficits and to evaluate the need for rehabilitation or assistance, but not to diagnose 
dementia. Cognitive tests should be easy to apply and should evaluate different 
cognitive domains, including language, neglect, memory, executive functions and 
attention. Mini Mental State Examination (MMSE) (28, 29) is used for global 
cognitive screening. Trail Making Test (TMT) A and B (30) measure psychomotor 
speed (A) and executive functioning (B). The Clock Drawing Test (31) primarily 
measures visuospatial functions in addition to executive functioning. 
 
1.1.4. Ischaemic stroke classification 
Ischaemic stroke can be classified into different subgroups, based on e.g. aetiology 
or topography. The classifications can help us distinguish between the subgroups 
of ischaemic stroke, and may be helpful in the acute phase when decisions about 
treatment should be done. They can also tell us about prognosis after stroke. In 
1993, the Trial of ORG 10172 in Acute Stroke Treatment (TOAST) (32) 
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developed a system based on diagnostic criteria to classify the subtypes of 
ischaemic strokes according to aetiology:  
 Large vessel atherosclerosis: Clinical and vessel imaging findings of either 
>50% stenosis or occlusion of a major brain artery or branch artery, 
presumably due to atherosclerosis. Clinical findings include those of cortical 
impairment or brain stem or cerebellar dysfunction. CT or MRI findings of 
cortical or cerebellar lesions or subcortical or brain stem lesions greater than 
1.5 cm in diameter. 
 Cardio embolic disease: Arterial occlusions due to an embolus arising in the 
heart. Clinical and brain imaging findings are similar to those described for 
large artery atherosclerosis. 
 Small artery occlusion: The patient should have clinical lacunar syndromes and 
no evidence of cerebral cortical dysfunction. Brain imaging is either normal or 
shows a brain stem or subcortical lesion less than 1.5 cm. Potential cardiac 
sources or large artery atherosclerosis in the ipsilateral artery should be absent. 
 Stroke of unusual aetiology: Patients with rare causes of stroke, such as 
nonatherosclerotic vasculopathies, hypercoagulable states or hematologic 
disorders. 
 Stroke of undetermined aetiology: No potential cause of stroke is found or 
more than one potential cause. 
 
This classification system is based on clinical and paraclinical findings including 
neuroimaging. TOAST is widely used in stroke-related research and clinical 
studies, and has been found to be valid and reliable (33). However, the criticism 
against TOAST, is that aetiological diagnoses are based on presumptions instead 
of pathological findings (34). Jackson and Sudlow (35) referred to the 
“Classification Bias”, the problem that risk factors are included in the definition of 
stroke subtype, and will result in a bias when risk factors are compared between 
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the different subtypes. Emboli from the heart or large vessel stenosis can 
occasionally occlude small, perforating cerebral vessels. It may be difficult to 
ascertain whether cardioembolic or large vessel disease is causal or a manifestation 
of generalised disease. Other classification systems such as Causative 
Classifications System (CCS) and ASCO (A for atherosclerosis, S for small vessel 
disease, C for cardiac source, O for other cause) have been introduced to improve 
the ability to identify the most likely cause where multiple potential mechanisms 
are found (36-38), but they have not been applied in larger studies. 
The Oxfordshire Community Stroke Project (OCSP) classification (39) is based on 
symptoms and signs, and allocate patients into four defined subgroups according to 
the topographic location and size: 
 Lacunar circulation infarcts (LACI): Patients present with a motor, sensory or 
sensorimotor syndrome or ataxic hemiparesis or dysarthria-clumsy-hand 
syndrome. The infarcts are confined to the deep perforating arteries.  
 Total anterior circulation infarcts (TACI): Patients present with symptoms of 
combined cortical deficit and ipsilateral motor and/or sensory deficit in at least 
two areas of the face, arm and leg. The infarcts involve both deep and 
superficial territories of the middle cerebral artery (MCA).  
 Partial anterior circulation infarcts (PACI): Patients present with only two of 
the tree components of the TACI syndrome, with cortical deficit alone or 
sensory and/or motor symptoms in face or one limb. The infarcts are more 
restricted cortical infarcts due to occlusion of the distal MCA. 
 Posterior circulation infarcts (POCI): Patients present with any of the 
following: ipsilateral cranial nerve palsy with contralateral motor and/or 
sensory deficit; bilateral motor and/or sensory deficit, disorder of the conjugate 
eye movement; cerebellar dysfunction without ipsilateral long-tract deficit; or 
isolated homonymous visual field defect. The infarcts are clinically associated 
with the brainstem, cerebellum or occipital lobes. 
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The OCSP classification is easy to apply and has a good interobserver reliability 
(40). However, the accuracy of the OCSP classification has been poor in patients 
with small infarcts (41). Both TOAST and OCSP are widely used in research 
studies and bedside in clinical practice.  
 
1.1.5. Brain imaging 
Brain imaging is mandatory to distinguish between an intracerebral haemorrhage 
and ischaemic stroke, and should be performed in the acute phase. Non-contrast 
cerebral CT is reliable in detecting acute haemorrhage (5), and is most easily 
accessible. Few acute ischaemic lesions can be seen the first hours, but they 
become visible over the first 1-7 days as dark hypodense areas. However, in many 
of ischaemic stroke patients, an infarct never becomes visible on CT (42). The 
proportion is higher in patients with milder strokes, i.e. lacunar infarcts, and the 
proportion visible also depends on timing of scanning. CT perfusion (CTP) can be 
a valuable tool in the diagnosis of ischaemic stroke, even though there are some 
limitations and pitfalls one should be aware of. CTP can be performed rapidly, and 
can distinguish the penumbra from the core infarct (43). CT angiography of 
precerebral and intracranial arteries is used to identify the site of the vessel 
occlusion. 
Magnetic Resonance Imaging (MRI) has similar accuracy as CT in detecting acute 
haemorrhage in patients presenting with stroke symptoms (44). The most sensitive 
method for early detection of cerebral ischemia is diffusion-weighted MRI (DWI) 
(45, 46). DWI measures the net movement of water in tissue due to random 
molecular motion of water. It shows hyperintense ischaemic tissue changes within 
minutes to a few hours after arterial occlusion due to a reduction of the apparent 
diffusion coefficient (ADC) (47).  Decreases in the ADC and increased signal on 
DWI in acute stroke may in many instances represent the ischaemic core. 
Perfusion-weighted MRI (PWI) reveals the perfusion deficit in the tissue 
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surrounding the infarct core. The DWI/PWI mismatch estimates the ischaemic 
penumbra, and can be useful in the selection of patients for reperfusion therapy, 
especially interventional therapy or unknown onset of symptoms. DWI is not 
available in the acute phase for all patients, but is superior to CT for the diagnosis 
of acute ischaemic stroke in patients presenting within 12 hours (47). 
 
1.1.6. Doppler Ultrasonography and further investigations 
Carotid Doppler Ultrasonography (CDU) should be performed during 
hospitalization, to search for the source of an embolus or vessel abnormalities in 
the precerebral arteries. The carotid bifurcation and the proximal part of the 
internal carotid artery are predilection sites for atherosclerotic plaques. The 
sensitivity and specificity of this non-invasive test for detecting a 70-99% stenosis 
in the carotids are high (48), and it has replaced intra-arterial angiography. CDU 
also visualizes the Intima Media Thickness (IMT) and may be used to measure 
different stages of the carotid artery atherosclerotic process.  
Transcranial Doppler Ultrasonography (TCD) is frequently used in patients with 
stroke, and provides information about intracranial hemodynamics and structural 
changes in the large vessels. It is used to detect intracranial stenosis and occlusion, 
and to evaluate revascularization after thrombolysis. In addition, continuous TCD 
monitoring may safely augment thrombolysis-induced arterial recanalization (49). 
Through the transtemporal window the circle of Willis, middle cerebral artery 
(MCA), the anterior cerebral artery (ACA) and posterior cerebral artery (PCA) can 
be visualized. The pulsatility index (PI) is derived from TCD, and was first 
described by Gosling and King (50). PI characterizes the shape of the spectral 
waveform and is independent of probe angle to vessel. It is postulated to reflect the 
vascular resistance in the artery distal of the probe, and has been reported to 
increase in small vessel disease, diabetes mellitus, ageing and dementia (51-55). 
Low-resistance vascular beds have high diastolic flow, whereas higher resistance 
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beds have low diastolic flow, a peaked waveform, and higher PIs. PI can be 
calculated using the formula PI = (peak velocity - end diastolic velocity)/mean 
velocity.  
Embolism from the heart is the cause in about 20% of all cerebral infarctions (5). 
Cardiac monitoring should be conducted routinely after an acute stroke to screen 
for serious cardiac arrhythmias (17). 24-48 hours Holter monitoring is used to look 
for atrial fibrillation in patients with suspected arrhythmias. If there is clinical 
evidence of cardiac disease, it is recommended to perform a transthoracic 
echocardiography (TTE), but transesophageal echocardiography is superior to TTE 
in identifying a cardiac embolic source, e.g. thrombus in the left atrial appendage, 
aortic atheroma and patent foramen ovale (56). 
 
1.1.7. Stroke risk factors 
Stroke prevention is about identifying subjects who are at increased risk for stroke, 
and to modify their risk if possible. Stroke risk factors are often classified as non-
modifiable or modifiable. Non-modifiable risk factors are higher age, male gender, 
ethnicity, heredity and previous stroke or TIA (57). Identification and control of 
modifiable stroke risk factors can result in marked reductions in stroke morbidity 
and mortality (58). Well-documented modifiable stroke risk factors are 
hypertension, diabetes, smoking, atrial fibrillation and certain other cardiac 
conditions, carotid artery stenosis, hypercholesterolemia, sickle cell disease, 
postmenopausal hormone therapy, poor diet, physical inactivity and obesity (57). 
Hypertension, diabetes and smoking are associated with more than half of all 
ischaemic strokes (57). Identification of risk factors in the individual patient is a 
part of the routine evaluation in the Stroke Unit, e.g. 24 h blood pressure (BP) 
measurement to look for hypertension, blood samples to look for coagulation 
disorders, etc. 
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1.1.8. Treatment and prognosis 
In the treatment of hyperacute ischaemic stroke, there are two strategies to follow. 
The first is limitation of the ischaemic stroke by early recanalization and 
reperfusion (thrombolysis or embolectomy). The other is interference with the 
pathophysiological cascade in the penumbral area, which includes monitoring and 
treatment of different factors, i.e. BP, hyperglycaemia, hyperthermia and low 
oxygen saturation. There are guidelines for treatment and rehabilitation of patients 
with acute ischaemic stroke (17-19) which include detailed recommendations 
based on current evidence. The time window for treatment of stroke is narrow, and 
every minute counts. It is important that the management of stroke patients is well 
organised, both outside and inside the hospital. Suspected stroke victims should be 
transported without delay to the nearest medical centre with a SU that can provide 
ultra-early treatment. Treatment in SUs has documented effect on outcome after 
acute stroke (59) and improves survival and functional outcome in the long term 
(60). The characteristics of a SU are systematic and standardised programs for 
diagnosis, monitoring and treatment of stroke by multidisciplinary teams. 
Intravenous thrombolysis with recombinant tissue plasminogen activator (rt-PA) 
within 4.5 hours of stroke onset offers beneficial effect in selected patients with 
acute ischaemic stroke (61). Patients with occlusion of large intracerebral arteries, 
who are not eligible for or do not improve after intravenous rt-PA, may be 
considered for intra-arterial thrombolysis or embolectomy (62). Patients who do 
not undergo interventional treatment, profit from receiving oral aspirin within 48 
hours of stroke onset (15). 
Secondary prevention depends on the underlying cause of stroke. Antiplatelet 
drugs are protective in most types of patients at increased risk of occlusive 
vascular events (63). For patients with cardioembolic disease, anticoagulant 
therapy is superior to antiplatelet drugs (64). New oral anticoagulants (NOACs) 
have documented similar efficacy as warfarin in the prevention of ischaemic 
stroke, and have a lower risk of intracerebral bleeding (65). If the patient has a 
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symptomatic carotid stenosis > 70%, carotid endartherectomy should be 
considered. Further treatment is aimed at the risk factors identified (17), e.g. 
hypertension and hypercholesterolemia. 
 
1.2. Cerebral small vessel disease 
More than a century ago, Otto Binswanger introduced the concept that diffuse 
white matter lesions could be attributed to small vessel disease (SVD), the 
narrowing of small penetrating vessels deep in the brain. These end arteries have 
no collateral supply and their occlusion results in small, discrete regions of 
infarction. SVD accounts for about 25% of all ischaemic strokes (66). SVD in the 
brain is characterised on neuroimaging by small subcortical infarcts, white matter 
hyperintensities, perivascular spaces, microbleeds and lacunes. French neurologists 
and neuropathologists in the early 19
th
 century introduced the term “lacune” on the 
small cavities they found in the brain at autopsy. Lacunes are defined as cavities 
filled with fluid, ranging from approximately 0.3 to 15mm
3
 in size. These lesions 
are typically located in the periventricular, deep subcortical white matter and basal 
ganglia, the same localisation as lacunar infarcts (67). Terminology and definitions 
for imaging the features of SVD vary widely. Wardlaw and colleagues from the 
Centres of Excellence in Neurodegeneration (68) have developed definitions and 
imaging standards for markers and consequences of SVD. 
Extensive white matter lesions in the elderly are generally ischaemic in origin and 
due SVD (69). In the Framington Offspring Study (70), they found that 10.7% of 
the participants with a mean age of 62±9 years had at least one brain infarct on 
MRI in the absence of any clinical evidence of stroke. MRI studies in the general 
population have shown that silent infarcts are present in a quarter or more of those 
aged >70 years, about five times more common than infarcts presenting with 
symptoms (71). The incidence increases significantly with age. The silent infarcts 
have the same risk factor profile as symptomatic infarcts, and are strongly linked 
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to hypertension and diabetes. They are associated with an increased risk of 
vascular events, cognitive decline and dementia, and frequently coexist with white 
matter lesions (71). SVD frequently coexists with neurodegenerative disease, and 
can worsen cognitive deficits, physical disabilities, and other symptoms of 
neurodegeneration (68).  
A number of studies have shown an association between retinal vasculature, renal 
dysfunction and cerebrovascular disease. Studies have reported an association 
between retinopathy and poorer cognitive function (72), and association between 
retinal vascular abnormalities and silent cerebral infarcts (73, 74). Chronic kidney 
disease is associated with white matter lesions and age-related macular disease 
(75-77). Thompson and Hakim (78) hypothesized that SVD is a systemic condition 
of aging that is exacerbated by vascular risk factors, which results from 
dysfunction of arteriolar perfusion. Systemic arteriolar dysfunction affects the 
brain as well as a number of extracranial systems. 
  
1.2.1. Lacunar infarct 
Lacunar infarcts (LIs) are small, subcortical infarcts typically located in the basal 
ganglia, thalamus, internal capsule, corona radiata or brainstem (79, 80). They are 
defined as <15 mm in diameter in the chronic phase, and are caused by occlusion 
of a single perforating end artery deep in the brain. Fischer demonstrated that LIs 
most often are due to lipohyalinosis and microatherosclerosis of the small 
penetrating vessels, and reported a strong association with SVD. He was of the 
opinion that SVD was due to hypertension. Hypertension, smoking and diabetes 
are important, but rather nonspecific risk factors for LI, and do not differ from 
other stroke subtypes (35, 79). Atrial fibrillation and carotid stenosis, however, are 
less common in LI (79, 81).  
Wardlaw et al.(68) have proposed terms and definitions for neuroimaging features 
of SVD. They have removed the word lacunar because of new evidence that not all 
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small subcortical infarcts become lacunes. These are the proposed novel terms for 
LIs: 
 Recent small subcortical infarct: neuroimaging evidence of recent infarction in 
the territory of one perforating arteriole, with imaging features or clinical 
symptoms consistent with a lesion occurring in the previous weeks. 
 Lacune of presumed vascular origin: a round or ovoid, subcortical, fluid-filled 
cavity of between 3mm and about 15mm in diameter, consistent with a 
previous acute small subcortical infarct or haemorrhage in the territory of one 
perforating arteriole. 
 
In my thesis, I have used the term acute lacunar infarct. 
Prognosis for patients with LI during the first years is more favourable in terms of 
survival and disability than for those with other stroke subtypes, probably because 
of the small lesion size. However, in the long term there is an excess risk for death, 
recurrent strokes, and development of cognitive dysfunction (66). Asymptomatic 
progression of SVD is several times more common than new strokes. At 10 years 
after onset of a LI, a third or less of patients are still alive and free of recurrent 
stroke (82), although a 15-20 % of survivors present cognitive impairment or 
vascular type dementia.  
 
1.2.2. Lacunar syndrome 
The clinical symptoms in patients with LIs were described by Fisher more than 30 
years ago (80, 83-85). Fisher correlated clinical features with autopsy findings, and 
described more than 20 different lacunar syndromes following LIs. Face, arm and 
leg involvement without cortical deficits (aphasia, apraxia, agnosia, neglect 
phenomena, loss of consciousness, etc.) or homonymous hemianopia are 
characteristic of the most frequent syndromes. The more restricted a deficit, the 
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more likely it is to arise from an infarct in the cortex, and not from a LI. The 
representations of areas are far more spread out in the cortex than in the 
corticospinal and sensory tracts (80). The most frequent of these clinical 
syndromes are: 
 Pure motor hemiparesis 
 Pure sensory stroke 
 Sensorimotor stroke 
 Dysarthria-clumsy hand syndrome 
 Ataxic hemiparesis 
The pure motor syndrome is typically caused by an acute LI in the internal capsule 
or in the brainstem, whereas the pure sensory syndrome in most cases can be 
explained by an acute infarct in the thalamus. In addition, LIs in the brainstem can 
result in ataxic hemiparesis or the dysarthria-clumsy-hand syndrome. Ischaemic 
lacunar strokes often progress and fluctuate during the first 24-38 hours after onset 
(79), making them the most common cause of “progressing stroke”. 
Traditionally it has been thought that LIs do not cause neuropsychological 
alterations. However, both LIs and SVD are associated with cognitive impairment 
and dementia (86-88). Studies have documented cognitive impairment in the acute 
phase (87, 89, 90) as well as in the long term (81, 86, 91). Impaired executive 
function and working memory have been highlighted as typical cognitive 
dysfunctions after lacunar stroke, but a systematic review by Edwards et al. 
documented that these dysfunctions were less characteristic for lacunar stroke than 
previously thought (92). Cognitive impairment in patients with lacunar stroke may 
be just as frequent and important as motor and sensory sequelae, but may be 
overlooked (93). 
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2. AIMS OF THESIS 
 
With this thesis, we want to elucidate different aspects of the lacunar infarct. In 
order to tailor the treatment to the individual patient with stroke, we need to know 
more about the different subtypes of stroke, clinical symptoms and risk factors. 
The aims of the present thesis are to: 
 Evaluate the diagnostic accuracy of the different lacunar syndromes in 
predicting lacunar infarcts on DWI. 
 Investigate risk factors associated with lacunar infarcts. 
 Compare blood pressure in patients presenting with clinical lacunar syndromes, 
but with different radiological subtypes of ischaemic stroke, in order to explore 
the impact of subtype on blood pressure in the acute phase. 
 Assess the association between cognitive impairment and Pulsatility Index in 
the middle cerebral artery. 
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3. MATERIAL AND METHODS 
 
3.1. Study design and subjects  
We conducted a prospective, observational hospital-based study at the Stroke Unit 
(SU), Department of Neurology, Akershus University Hospital, from February 
2011 to January 2013.  
Consecutive patients presenting with an acute lacunar syndrome who were 
admitted to the SU were recruited. The patients underwent standard examination at 
our SU including blood samples, electrocardiogram records (ECG), cerebral CT at 
admission and colour duplex of precerebral and intracranial arteries. All included 
patients were examined clinically by an experienced stroke neurologist (MA).  
The diagnosis of a lacunar syndrome was based upon the patients’ history and 
neurological examination (findings compatible with a lacunar syndrome). Patients 
who were treated with intravenous thrombolysis were included, even when their 
symptoms lasted less than 24 hours. Exclusion criteria were intracerebral 
haemorrhage and transitory ischaemic attack (TIA, symptoms lasting <24 h and no 
visible infarct on imaging). 
 
3.2. Assessments 
Neurological impairment was assessed by the neurologist on call at admission and 
on day one and at discharge by MA, using an 11-items version of the NIHSS 
(Appendix 1). Global function was evaluated using the mRS (Appendix 2) at 
discharge. Cognitive function was evaluated by MMSE (Appendix 3), Clock 
Drawing Test (Appendix 4) and TMT A and B (Appendix 5, 6), which are the 
standardised battery of cognitive assessments at our SU. These were performed 
between day 2 and day 5 by occupational therapists at the SU. In addition, Barthel 
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ADL index (Appendix 7) was recorded at discharge. Evaluations and 
investigations are listed in Table 1. 
 
Table 1. Evaluations and investigations  
From Paper I, reprinted with permission from Elsevier. Copyright 2014. 
 
Inclusion criteria     Acute clinical lacunar syndrome 
Exclusion criteria     Intracerebral Haemorrhage, TIA 
Standard examination    Blood tests 
       ECG 
       Pre-/intracerebral colour duplex 
Classifications   NIHSS, OCSP, TOAST, mRS, 
                                                                   Barthel ADL index 
Radiology   CT at admission 
                                                                   MRI after the acute phase 
Risk factors registration   Hypertension 
   Diabetes 
   Hypercholesterolemia 
   Coronary heart disease 
   Atrial fibrillation 
   Previous stroke or TIA 
   Large vessel disease 
       Current smokers 
Abbreviations: ADL, Activity of Daily Living; mRS, modified Rankin Scale; 
NIHSS, National Institutes of Health stroke scale; OCSP, Oxfordshire Community 
Stroke Project; TOAST, Trial of ORG 10172 in Acute Stroke Treatment 
 
We registered risk factors (hypertension, diabetes, hypercholesterolemia, atrial 
fibrillation, coronary heart disease (previous myocardial infarction or angina 
pectoris), mechanical heart valve, smoking and previous stroke/TIA). Prestroke 
hypertension was defined as on-treatment with antihypertensive drugs, elevated BP 
as systolic BP>140 mmHg. Hypercholesterolemia was defined as on-treatment 
with lipid-lowering drugs or total cholesterol >5 mmol/L or low-density 
lipoprotein cholesterol >3 mmol/L.  
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BP registrations were performed immediately after admission and bedside in the 
morning on day three, and were registered prospectively. BP measurements were 
performed according to standardized protocol, with fully automatic arm BP 
monitors with the patient in a supine position. 
Patients were examined with Doppler ultrasonography of precerebral and 
intracranial arteries within three days of admission. The examination was 
performed by one neurologist (M.A.) using GE Vivid 7 Dimension, 4 MHz probe. 
The middle cerebral arteries (MCAs) were insonated through the transtemporal 
window at a depth of 50 to 60 mm. The vascular peak systolic velocity, pulsatility 
index (PI), spectrum shape and direction of blood flow in the proximal MCA (M1) 
were observed and recorded. The PI value was automatically calculated by the 
Doppler machine (according to the formula PI= (systolic flow velocity – diastolic 
flow velocity)/mean flow velocity). A mean MCA PI was calculated by averaging 
the MCA PI from both hemispheres. If the patient only had good temporal window 
on one side, unilateral MCA PI was considered as mean PI. Findings of 
symptomatic carotid or middle cerebral artery stenosis >50 % were registered.  
Patients underwent magnetic resonance imaging (MRI) with diffusion-weighted 
images (DWI) within a week after admission to hospital. The brain imaging was 
done on Philips Achieva 1,5T or 3T MRI scanners employing standard sequences, 
using T1 weighted sagittal, T2 weighted axial, T2/FLAIR weighted coronal and 
diffusion weighted (DWI) axial imaging. Due to capacity problems in the MRI 
scanning, 33 patients underwent only CT scanning. Isolated acute ischaemic 
lesions on DWI or CT were defined as LIs if <15 mm and located subcortically or 
in the brainstem (94), whereas all other acute ischaemic lesions were defined as 
non-lacunar infarcts (NLI).  
Figure 3 shows the patient subgroups included in the three papers in the present 
thesis. 
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Figure 3. Patient subgroups in Paper I-III 
Abbreviations: CT, Computer tomography; DWI, diffusion weighted imaging 
1
 Facial paresis or symptoms in only one limb  
 
 
3.3. Statistics 
Data were analysed using SPSS (SPSS Inc., Chicago IL) version 19 (paper I and 
II) and version 22 (paper III). All significance tests were two-tailed and performed 
at the 5% level. Continuous variables were presented as means and standard 
deviations (SD) or medians and the interval between first (Q1) and third (Q3) 
quartiles. Categorical variables were presented as frequencies and percentages. 
Normality of continuous variables was assessed by inspecting the histograms. 
Between-group differences of the characteristics and stroke risk factors were 
compared using independent samples t-test for normally distributed continuous 
data, Mann-Whitney test for skewed continuous data, and χ2-test for categorical 
variables. 
147 patients with clinical lacunar syndrome recruited 
86 patients 
Paper I 
 
113 patients  
Paper II+III 
 
No acute lesion on 
CT or DWI           
n=34 
No DWI 
performed        
n=37 
Monoparesis
1
      
n=24 
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The associations between an outcome and candidate variables were assessed by 
linear regression models for continuous outcomes and logistic regression models 
for dichotomous outcomes. These results were presented as regression coefficients 
or ORs with standard errors and corresponding p-values. 
In paper I, the sensitivity and specificity of the different lacunar syndromes were 
assessed using DWI as reference test (“gold standard”). 
Detailed descriptions of the statistical methods are presented in each paper. 
 
3.4. Ethical considerations 
The study was approved by The Regional Committee for Ethics in Medical 
Research and by the Data Protection Authorities. Oral and written informed 
consent was obtained from all included patients. There was no benefit for patients 
participating in the study, neither any disadvantage for those who did not. All 
patients were managed according to a standard stroke protocol. 
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4. SUMMARY OF RESULTS 
 
4.1. Paper I  
Diagnostic accuracy and risk factors of the different lacunar syndromes 
A total of 86 patients were included. 69 patients (80.2%) had an acute ischaemic 
lesion on DWI, only 6 (8.7%) of these appeared on the initial CT. 56 patients 
(65.1%) had a lacunar lesion, 13 patients (15.1%) had one or more non-lacunar 
lesions. 17 patients had no sign of acute infarct. We used DWI as a gold standard 
for having lacunar infarction, and the positive predictive value (PPV) of the 
lacunar syndrome was 65.1% (56/86). The PPV of the pure motor syndrome was 
75% and of the sensorimotor syndrome was 48%. 41 patients had “biparesis” and 
45 had “triparesis” (symptoms in arm and leg + facial paresis). We calculated the 
sensitivity and PPV for patients presenting with motor syndrome and triparesis, but 
this did not change the values.  
 
Table 3. Sensitivity and specificity of the different lacunar syndromes 
Adapted from paper I, reprinted with permission from Elsevier. Copyright 2014. 
 
 
 
 
 
 
 
There were no significant differences between the groups regarding vascular risk 
factors. In the multivariate logistic regression model, pure motor syndrome [OR 
Clinical presentation Sensitivity Specificity PPV NPV 
Motor syndrome 0.68 0.57 0.75 0.49 
Sensorimotor syndrome 0.23 0.53 0.48 0.27 
Motor syndrome with triparesis 0.67 0.60 0.77 0.47 
Abbreviations: NPV, negative predictive value; PPV, positive predictive value 
36 
 
2.66 (1.04-6.80)] and male gender [OR 2.63 (1.01-6.83)] were the only variables 
with significant associations with LI on DWI. 
 
4.2. Paper II 
Blood pressure differences between patients with lacunar and non-lacunar 
infarcts  
In all, 113 patients were included. 85 patients (75.2%) had a LI, 28 patients 
(24.8%) had one or more NLIs. The LIs were localized in the basal ganglia (44%), 
the periventricular white matter (21%), the thalamus (14%) and in the brainstem 
(21%). The NLIs were localized in the cortex or subcortically, but none were due 
to occlusion of a major vessel. None of the NLIs located subcortically were lesions 
consistent with occlusion of a single perforant artery. 
The mean age was 70.1 years (SD=11.5), and 69% were men. The median NIHSS 
score was 3 (IQR 2-4) at admission and 1 (IQR 0-3) at discharge, whereas median 
mRS score was 2 (IQR 1-3) at discharge and median Barthel ADL index (day 2-4) 
was 20 (IQR 16-20). 75.2 % of the patients had systolic BP>140 mmHg at 
admission and 54.9% had used antihypertensive medication before admission 
(prestroke hypertension). There were significantly more patients with systolic 
BP>140 mmHg among patients with LI than NLI at day three (p=0.020). The 
systolic BP at day three was significantly higher in the LI group than the NLI 
group (p=0.002).  
In the linear regression model, there was a significant association between systolic 
BP and LI, both at admission (p=0.042) and at day three (p=0.003). Adjusting for 
covariates (age, gender, smoking, prestroke hypertension, diabetes, 
hypercholesterolemia, large vessel disease and NIHSS), these associations were 
still significant (p=0.047 and p=0.006, respectively). There was also a significant 
association between diastolic BP at day three and LI (unadjusted, p=0.005, 
adjusted, p=0.036). None of the other covariates were significantly related to the 
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BP. BP was not associated with mRS or NIHSS at discharge (p=0.777 and 
p=0.887 respectively). 
 
4.3. Paper III 
Pulsatility index in the middle cerebral artery- associated with cognitive 
impairment in lacunar stroke? 
In all, 113 patients were included. The mean MMSE score was 26.1 (SD=3.6), and 
43% scored ≤26. The mean TMT A time was 72.6 seconds (SD=43.8) and the 
mean TMT B time was 195.1 seconds (SD=107.8). 47% had a TMT B age 
adjusted score ≥2SD (95). 68.1% of the patients had a normal Clock Drawing Test 
score. Adequate Transtemporal window for Doppler data was achieved in 84% of 
the patients. The mean PI was 1.46 (SD=0.33). Characteristics and stroke risk 
factors are presented in Table 2. We found no statistically significant difference in 
PI between patients with lacunar and non-lacunar infarcts. 
There were no statistically significant differences between lacunar and non-lacunar 
infarct groups with respect to the association between PI and the different outcome 
variables. PI was significantly (p<0.05) associated with MMSE, TMT A and TMT 
B in the LI group, even after adjustment for a number of patient characteristics 
(age, sex, prestroke hypertension, smoking, previous stroke and diabetes). The 
Clock Drawing Test was not significantly associated with PI (unadjusted p=0.057, 
adjusted p=0.348).  
 
4.4. Characteristics and vascular risk factors of the population 
A total of 147 patients with a lacunar syndrome were recruited to the study. 
Characteristics and vascular risk factors of the population are presented in Table 2. 
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Characteristics and vascular risk factors 
All patients 
n=147 
Paper I 
n=86 
Paper I+II 
n=113 
Age, mean (SD) 70.3 (11.9) 69.3 (12.1) 70.1 (11.5) 
Males 87 (59) 56 (65) 78 (69) 
Performed only CT 37 (25) 0 18 
Verified infarct 113 (77) 69 (80) 113 (100) 
Verified lacunar infarct 85 (58) 56 (65) 85 (75) 
Monoparesis
1 
28 (19) 0 25 (22) 
Current smokers 50 (34) 32 (37) 39 (35) 
Hypertension 83 (57) 48 (56) 62 (55) 
Diabetes 36 (25) 14 (16) 28 (25) 
Hypercholesterolemia
2 
113 (73) 65 (76) 86 (76) 
Coronary disease
3 
27 (18) 19 (22) 21(19) 
Large vessel disease
4 
19 (13) 15 (17) 17(15) 
Atrial fibrillation 19 (13) 12 (14) 16 (14) 
Previous stroke or TIA 30 (20) 17 (20) 20 (18) 
Blood pressure >140 day 3 92 (63) 50 (58) 85 (75) 
NIHSS at admission, median, (IQR) 3 (2-4) 3 (2-4) 3 (2-4) 
NIHSS at discharge, median, (IQR) 1 (0-3) 1,5 (0-3) 1 (0,5-3) 
Barthel ADL index , median, (IQR) 20 (17-20) 20 (16-20) 20 (16-20) 
mRS at discharge, median, (IQR) 2 (1-3) 2 (1-3) 2 (1-3) 
Treated with iv thrombolysis 15 (10) 9 (11) 10 (9) 
Abbreviations: ADL, Activities of Daily Living; iv, intravenous; IQR, Interquartile range; 
mRS, modified Rankin Scale; NIHSS, National Institutes of Health Stroke Scale; SD, 
Standard deviation. 
1 
Symptoms only in 1 limb or facial paresis 
2
 On-treatment with statins or total cholesterol >5 mmol/L and/or LDL cholesterol >3mmol/L  
3
 Previous myocardial infarction and/or angina pectoris 
4
 >50% stenosis in the internal carotid artery or middle cerebral artery 
Results are n and (%) unless indicated otherwise 
Table 2.Characteristics and vascular risk factors  
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5. GENERAL DISCUSSION 
 
Stroke is a common disorder, and lacunar infarcts account for about 25% of all 
ischaemic strokes (81, 96). LIs can be symptomatic or asymptomatic, and are a 
part of the term SVD. In the short term, the clinical course is characterised by a 
low early mortality and relatively preserved neurological functioning, however, in 
the long term it is characterised by increased risk of death, stroke recurrence and 
dementia. Therefore, LIs should be regarded as a potentially severe condition that 
requires thorough evaluation, management and follow-up.  
 
5.1. Diagnostic accuracy of the lacunar syndromes 
Stroke in the acute phase is a clinical diagnosis. The clinical lacunar syndromes are 
well described, but how well can clinical neurological examination predict a LI? In 
our study, the lacunar syndrome had an overall low positive predictive value of 
65.1% for predicting an acute LI on DWI. This is in accordance with previous 
DW- MRI studies (41, 46). The PPV was particularly low among patients with a 
sensorimotor syndrome (48%), which is no better than by chance. Previous reports 
(97-99), which have shown a high diagnostic accuracy of the lacunar syndrome, 
used only CT or conventional MRI. In these studies, patients with no verified 
infarct on CT/MRI were either excluded or classified as LIs (97, 99, 100), which 
may have resulted in a falsely elevated PPV of the lacunar syndrome. The 
radiological diagnosis of stroke has been largely improved with early diffusion 
weighted imaging (DWI), at present the most sensitive imaging in acute ischaemic 
stroke (46).   
Recent studies using DWI have demonstrated that the OCSP classification has a 
particularly low PPV in predicting infarct location of small infarcts (41, 101). One 
of these studies found a PPV of LACI as low as 39% (41). These results 
demonstrate that the OCSP classification does not permit accurate discrimination 
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between lacunar and small cortical infarcts, which is in accordance with the 
findings in our study. 
In our study, 17 patients had no recent ischaemic lesion on DWI at all. Four of 
these had been given intravenous thrombolytic treatment, which may explain the 
absence of an ischaemic lesion. The remaining 13 patients constitute 15.1% of all 
patients. False-negative DWI cases do occur (47), even though DWI has a high 
sensitivity for detecting acute ischaemic lesions. This is particularly the case for 
small ischaemic lesions, especially lacunar infarcts and infarcts located in the brain 
stem (102). The majority of our patients had minor stroke, and we would expect a 
higher proportion of false negative DWIs. Some of the 13 patients might have had 
a non-ischaemic diagnosis (a stroke mimic) such as migraine, functional paresis 
etc. (103). In clinical practice, these differential diagnoses may be challenging. 
We found no significant differences in risk factors between the groups (LI vs. no 
LI). This has also been described in other studies (97, 104). Hypertension, smoking 
and diabetes are important but rather nonspecific risk factors for LIs, and do not 
differ from other stroke subtypes. When we compared the two groups of patients 
with an acute ischaemic lesion on DWI, lacunar or non-lacunar, the latter were 
older and had a higher frequency of atrial fibrillation at admission and large vessel 
stenosis (not statistically significant). We only included patients with lacunar 
syndrome, and therefore the number of patients with cortical lesions was probably 
too low to reach significant differences. Others have reported significantly higher 
proportion of large vessel disease or atrial fibrillation among patients with cortical 
infarcts (101, 105).  
 
5.2. Blood pressure differences between lacunar and non-lacunar 
infarcts  
Patients with acute LIs had significantly higher BP on day three compared to 
patients with acute NLIs. This applies to both diastolic and systolic BP. The 
41 
 
difference was significant regardless of prestroke hypertension. We also found a 
significant association between BP and LI, both at admission and day three. 
Previous studies comparing BP in patients with different subtypes of stroke have 
compared groups with different severity of neurological impairments. In patients 
with major stroke, BP may rise because of large volume effect and high 
intracranial pressure, as a compensatory mechanism. This was most likely not the 
case in our study, as none of the NLIs were due to occlusion of a major vessel. 
Accordingly, there was probably no oedema-effect on the BP in any of the groups.  
Previous studies on the association between different subtypes of stroke and 
different patterns of BP change in acute stroke have shown conflicting results. 
There are publications reporting highest BP levels in patients with lacunar strokes 
(106-108), while others found higher BP levels from day one in patients with non-
lacunar strokes compared to lacunar strokes (109).
 
Vemmos et al. found no 
significant difference in BP levels between the different aetiological subtypes of 
stroke (110). In that study, the spontaneous BP variation in acute stroke differed 
according to subtypes, with a milder drop in cardio embolic strokes compared to 
end artery small vessel and large vessel atherosclerotic strokes. BP was 
proportional to the clinical severity of stroke at presentation, which can be 
explained by the fact that cerebral ischemia might trigger a physiological response, 
resulting in higher BP. In the study of Vemmos, there was probably a large 
oedema effect on the BP in the groups with high clinical severity.
 
Other studies (106, 107) have reported findings of higher BP in patients with LIs 
than in NLIs, which corresponds to the findings in our study. Semplicini et al. also 
found that the outcome of stroke was highly associated with subtype of stroke and 
initial BP (106), as lacunar stroke and patients with the highest BP on admission 
had the best prognosis. In our study of patients with lacunar syndromes, the 
patients had the same severity regardless of subtype of stroke. Both groups had a 
good clinical outcome with low NIHSS and mRS scores at discharge. There was 
no association between BP and outcome. Many studies have looked at the 
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association between admission BP and outcome, and have shown inconsistent 
results (13, 25-27).
 
Two studies found that high BP is associated with poor 
outcome (111, 112). They did not look at differences between subtypes of stroke. 
Kvistad et al. found an inverse association between BP and stroke severity on 
admission, where elevated BP was associated with mild stroke, and lack of 
elevated BP was associated with severe stroke (113). They assumed that there 
might be a protective effect of elevated BP. But maybe the high BP in lacunar 
stroke is a marker of the underlying cause, and not necessarily a protective 
mechanism? In previous studies exploring the association between stroke subtype, 
BP and outcome, the severity differs between the subtypes. As long as studies 
compare groups with different severity of neurological deficits, we will not get the 
answer of whether differences in BP are explained by aetiological subtype or 
severity.  
Fifty percent of the patients in our study used antihypertensive treatment at 
admission, and there were no significant difference regarding prestroke 
hypertension between the two groups. Still, the BP at day three was significant 
higher in the LI group (and there was a trend toward higher systolic BP at 
admission). LIs were independently associated with a higher BP compared to NLIs 
with the same severity of neurological impairments. The sustained high BP in the 
LI group may be an indication of untreated (or suboptimally treated) chronic 
hypertension. Recent data from the SPS3 trial (114) have recommended a lower 
BP target (systolic BP<130 mmHg) for patients with recent LI. Optimal BP control 
may reduce white matter hyperintensity progression and cognitive impairment of 
vascular type (115). 
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5.3. The association between PI and cognitive impairment in lacunar 
stroke 
The TCD PI values were significantly associated with MMSE, TMT A and TMT B 
performances in patients with a LI. Our results correspond to the findings in a 
study of asymptomatic participants between 50-65 years by Lopez-Oloriz et 
al.(116). In a study of cerebrovascular hemodynamics in patients with Alzheimer’s 
disease and vascular dementia (117), the authors found that PI was significantly 
higher in patients with vascular dementia compared to patients with Alzheimer’s 
disease. Elevated PI may be an indicator of SVD, as it is believed to reflect the 
resistance in the arteries deep in the brain (52). We found no statistically 
significant differences between LI and NLI groups with respect to the association 
between PI and cognitive tests. This may be due to a too small NLI group, and to 
the fact that the NLI group of the present study is a highly selected group in which 
all patients presented with a lacunar syndrome, and none had an occlusion of a 
major vessel. They do not represent a typical NLI group among patients with 
stroke, and SVD may have been prevalent in this particular NLI group. Well 
known risk factors for SVD such as hypertension, diabetes and other 
cerebrovascular risk factors were equally present in both groups.  
MMSE is frequently used for global cognitive screening, but may lack sensitivity 
in patients with stroke (118) . Nevertheless, there is a strong association between 
MMSE and PI values in both groups in our study, even after adjustment for 
multiple relevant variables. An elevated PI predicts a low score on MMSE. In our 
models, we adjusted for previous stroke, age, hypertension and diabetes. Prior 
stroke and age are well recognized predictors of cognitive impairment. TMT A and 
B are also a part of our standard test battery for patients with stroke. TMT A 
measures psychomotor speed, while TMT B measures visual attention information 
processing and executive functioning. Impairment in these functions is often 
associated with LIs and SVD. The association between PI and TMT A remained 
significant in both groups after adjustment. The association between PI and TMTB 
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after adjustment was only present in the LI group. This may suggest a stronger 
association between PI and TMT B in LIs compared to NLIs, but further studies 
with larger samples are needed to confirm this finding. In a quantitative systematic 
review by Edwards and colleagues (92), the authors reported impairment in 
multiple cognitive domains following LI. In addition to the domains of 
attention/working memory and executive functioning, the impairment was also 
reported for memory, language and visuospatial function. The magnitude of 
impairment was actually largest for global cognition and information processing 
speed. They found no evidence for change in domain-specific cognitive function 
over time, and assumed that the longer-term rate of cognitive decline is due to 
stroke recurrence. The Secondary Prevention of Small Subcortical Strokes (SPS3) 
clinical trial (119) examined domain-specific cognitive outcomes in patients with 
symptomatic LIs (93). In this study, they found episodic memory deficits in 
patients in addition to the typical impairment pattern for SVD. Mild cognitive 
impairment was present in almost half of their participants, and was more 
prevalent than physical disability defined by mRS ≥2. This is in accordance with 
the findings in our study, although we did the testing in the acute phase after 
stroke. More than 40 % of the patients in the LI group in our study had a MMS 
score ≤ 26, while 39% had mRS ≥2. Cognitive impairment after lacunar stroke is 
common, and may have a major impact on the patient’s quality of life. 
In the multivariate analyses of the association between PI and MMSE, diabetes 
was also a strong predictor of low MMSE score. Diabetes is an independent risk 
factor for ischaemic stroke, including lacunar infarction (81), and has previously 
been found to be independently associated with a high PI (120). In the SPS3 trial 
(121), they found that patients with diabetes mellitus had more extensive white 
matter disease and were almost twice as likely to have a recurrent stroke compared 
to patients with LI without diabetes. The association between cognitive 
impairments and diabetes may be a result of SVD. In our study, diabetes was 
actually more prevalent in the NLI-group (32 vs. 22%). The difference is not 
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significant, but may support the hypothesis that SVD co-exists in some of the 
patients in the NLI-group as well.  
 
5.4. Methodological considerations 
Akershus University Hospital has a well-defined catchment area, which accounts 
for about 10 % of the Norwegian population. All patients with suspected stroke or 
TIA are admitted to the SU for further examination, but there will always be some 
patients who do not seek medical contact. The patients included were diagnosed 
according to the criteria for a lacunar syndrome, and the median NIHSS was low. 
The study population should represent a general lacunar stroke population. 
Strengths of the study are that all patients were included and examined by one 
person, and all patients consented to the study. 
The prospective design of the study including consecutive patients with a lacunar 
syndrome reflects the real life experience in a SU. The main investigator 
performed the clinical examination and Doppler ultrasound measurements on all 
patients, and the data were recorded prospectively. Because the investigator 
attended various courses as part of the PhD program, there were periods without 
inclusion. However, these periods were spread throughout the year, and were not 
on specific months or days. This should therefore not entail any selection bias. 
A limitation of our study in comparing lacunar and non-lacunar infarcts was the 
small sample size in the NLI group, which may entail too little power to discover 
between-group differences. In the beginning of the study period, the hospital 
experienced capacity problems in MRI scanning, and many patients underwent 
only CT scanning. This led to exclusion of many patients in the first study. 
Another limitation is that we do not have data on the severity of white matter 
disease in our patients. 
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In the first paper, we evaluated the diagnostic accuracy of the different lacunar 
syndromes by calculating the sensitivity, specificity and positive predictive value, 
see table 4. The sensitivity of a test is the proportion of people with a disease that 
will be correctly diagnosed by the test. The specificity is the proportion of people 
without a disease that actually is identified as negative by the test. In a screening 
situation, high sensitivity is important if a false negative error is serious, while a 
high specificity is important to avoid false positive errors. The “optimal test” has 
both high sensitivity and high specificity. In clinical practice, the positive and 
negative values may be more useful. The positive predictive value (PPV) is a 
measure of the probability that a patient with a positive test result really has the 
condition he/she is tested for. The PPV is dependent upon the prevalence of the 
disease, and if the prevalence is low, the PPV will decline. In our study a positive 
predictive value for the lacunar syndrome is the probability that the patient who 
present with a lacunar syndrome actually has a LI on DWI. 
 
Table 4. Sensitivity, specificity and predictive value of the motor syndrome 
 Diffusion weighted 
imaging 
  
  LI No LI Total  
Motor 
syndrome 
Yes 38 13 51 PPV=38/51=75% 
No 18 17 35 NPV=17/35=49% 
 Total 56 30 86  
  Sensitivity= 
38/56=68% 
Specificity= 
17/30=57% 
  
NPV, negative predictive value; PPV, positive predictive value 
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We used the DWI as a gold standard. Although DWI has a high sensitivity, false-
negative DWI cases do occur (47). Baseline DWI volume is considered useful in 
predicting final lesion volume in anterior-circulation stroke syndromes, but DWI-
positive scans in TIA are also common (47). Studies have shown acute ischaemic 
DWI lesions in among 40% of the patients with a clinical diagnosis of TIA, a 
finding that may correlate with symptom duration. Whether a TIA with DWI 
lesions is to be classified as a cerebral infarct is still under debate (122). In our 
study, we included only patients with symptoms lasting more than 24 hours, except 
from the patients who were treated with thrombolysis.  
BP registrations in our study were performed immediately after admission and 
bedside in the morning on day three, and were registered prospectively. BP 
measurements were performed according to a standardized protocol, with fully 
automatic arm BP monitors with the patient in a supine position. Unfortunately, we 
did not have the possibility to use 24 hours BP measurements on our patients. It is 
known that BP is transiently elevated in patients with acute stroke with a 
spontaneous decrease within the following days (123-126).We therefore chose two 
points in time to measure the BP. None of the patients were treated with 
intravenous antihypertensive drugs in order to reduce BP. The median time 
interval from onset of symptoms to admission to hospital was 11 hours, and there 
was no significant difference between the groups according to this. It is known 
from previous studies (127, 128) that stroke severity is related to prehospital delay. 
Patients with a higher NIHSS score arrive faster to hospital than patients with a 
low NIHSS. 
In Paper III we measured the pulsatility index in the middle cerebral artery. The PI 
value was automatically calculated by the Doppler machine using the mean of 5 
cycles, and a mean PI was calculated by averaging the PI from both hemispheres. 
Our mean PI value is higher than in other studies (52). Previous studies have 
shown an elevation in PIs with increasing age, hypertension and SVD (51-55), 
which all are factors prevalent in our highly selected population. We included only 
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patients with lacunar syndromes and verified acute infarcts. The patients were 
examined in the acute phase, which also may have an effect on the PI values. 
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6. CONCLUSIONS 
 
 The present study has demonstrated a low diagnostic accuracy of the clinical 
lacunar syndrome. It is important to be aware of this uncertainty in clinical 
practice. The clinical diagnosis of patients with lacunar syndromes is 
inaccurate, especially among patients with non-motor syndromes. DWI is 
mandatory for obtaining an accurate diagnosis of the lacunar infarct.   
 
 Lacunar infarcts may be independently associated with higher blood pressure 
compared to non-lacunar infarcts with the same severity of neurological 
impairments. Blood pressure differences between different subtypes of stroke 
may not only be related to clinical severity but also to the underlying cause of 
stroke. Hypertension is strongly linked to lacunar infarcts as a risk factor.  
 
 Pulsatility index was associated with the cognitive performance in patients with 
lacunar infarcts. An elevated PI may be related to impairment in several 
cognitive domains. These findings suggest that TCD may be a useful 
supplement to other cognitive investigations in clinical practice.   
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7. FURTHER PERSPECTIVES 
 
We hope that the papers included in this thesis will help draw attention to lacunar 
infarcts. A correct diagnosis is important because it has implications for further 
investigations and treatment. Because of the low diagnostic accuracy of the lacunar 
syndromes, the radiological verification of infarcts in future studies on stroke is 
essential to differentiate between subtypes of stroke.  
Further studies of blood pressure in the different aetiological subtypes of stroke are 
needed in order to differentiate treatment. It is important to use risk-factor-free 
classifications of stroke subtypes when comparing risk factor profiles between 
lacunar and non-lacunar subtypes (35). Better knowledge regarding the impact of 
the risk factors for different subtypes of stroke may give rise to more specific 
approaches to therapy.  
We need further studies on BP lowering in patients with small vessel disease, to 
evaluate how they respond to BP treatment. Maybe more aggressive treatment in 
the long term can stop or even reverse the white matter progression? The SPS3 
trial (114) has already suggested a lower BP target (systolic BP<130 mmHg) for 
patients with recent LI. 
The findings of the association between PI and cognitive performances in patients 
with LIs suggest that TCD may be a useful supplement to other cognitive 
investigations in clinical practice. Further studies will be required to look at the 
association between PI and cognitive impairment in different subtypes of stroke.  
 
52 
 
  
53 
 
8. REFERENCES 
 
1. Aho K, Harmsen P, Hatano S, Marquardsen J, Smirnov VE, Strasser T. 
Cerebrovascular disease in the community: results of a WHO collaborative 
study. Bulletin of the World Health Organization. 1980;58(1):113-30. 
 
2. A classification and outline of cerebrovascular diseases. II. Stroke 
1975;6(5):564-616. 
 
3. Kidwell CS, Alger JR, Di Salle F, Starkman S, Villablanca P, Bentson J, et 
al. Diffusion MRI in patients with transient ischemic attacks. Stroke 
1999;30(6):1174-80. 
 
4. Easton JD, Saver JL, Albers GW, Alberts MJ, Chaturvedi S, Feldmann E, et 
al. Definition and evaluation of transient ischemic attack: a scientific 
statement for healthcare professionals from the American Heart 
Association/American Stroke Association Stroke Council; Council on 
Cardiovascular Surgery and Anesthesia; Council on Cardiovascular 
Radiology and Intervention; Council on Cardiovascular Nursing; and the 
Interdisciplinary Council on Peripheral Vascular Disease. The American 
Academy of Neurology affirms the value of this statement as an educational 
tool for neurologists. Stroke 2009;40(6):2276-93. 
 
5. Warlow C, Sudlow C, Dennis M, Wardlaw J, Sandercock P. Stroke. Lancet 
2003;362(9391):1211-24. 
 
6. Fisher M, Bastan B. Identifying and utilizing the ischemic penumbra. 
Neurology 2012;79(13 Suppl 1):S79-85. 
 
7. Ginsberg MD, Pulsinelli WA. The ischemic penumbra, injury thresholds, 
and the therapeutic window for acute stroke. Ann Neurol 1994;36(4):553-4. 
 
8. Hossmann KA. Viability thresholds and the penumbra of focal ischemia. 
Ann Neurol 1994;36(4):557-65. 
 
9. Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, Aboyans V, et al. 
Global and regional mortality from 235 causes of death for 20 age groups in 
1990 and 2010: a systematic analysis for the Global Burden of Disease 
Study 2010. Lancet 2012;380(9859):2095-128. 
 
 
 
54 
 
10. Truelsen T, Begg, S., Colin, M. The global burden of cerebrovascular 
disease. World Health Organization web side. 
http://www.who.int/healthinfo/statistics/bod_cerebrovasculardiseasestroke.p
df?ua=1. Accessed June 2, 2015 
 
11. Feigin VL, Forouzanfar MH, Krishnamurthi R, Mensah GA, Connor M, 
Bennett DA, et al. Global and regional burden of stroke during 1990-2010: 
findings from the Global Burden of Disease Study 2010. Lancet 
2014;383(9913):245-54. 
 
12. European Registers of Stroke I, Heuschmann PU, Di Carlo A, Bejot Y, 
Rastenyte D, Ryglewicz D, et al. Incidence of stroke in Europe at the 
beginning of the 21st century. Stroke 2009;40(5):1557-63. 
 
13. Ellekjaer H, Selmer R. Stroke -similar incidence, better prognosis. Tidsskr 
Nor Laegeforen 2007;127(6):740-3. 
 
14. Statistics Norway. 2015.Web side. https://www.ssb.no/statistikkbanken. 
Accessed June 2, 2015 
 
15. Donnan GA, Fisher M, Macleod M, Davis SM. Stroke. Lancet 
2008;371(9624):1612-23. 
 
16. Norwegian Board of Health Supervision. Scenario 2030. 
Sykdomsutviklingen for eldre fram til 2030. Oslo, 1999. Available from: 
https://www.helsetilsynet.no/upload/Publikasjoner/utredningsserien/2030_s
ykdomsutvikling_eldre_ik-2696.pdf. Accessed June 2, 2015. 
 
17. Guidelines for management of ischaemic stroke and transient ischaemic 
attack 2008. Cerebrovasc Dis 2008;25(5):457-507. 
 
18. Jauch EC, Saver JL, Adams HP, Jr., Bruno A, Connors JJ, Demaerschalk 
BM, et al. Guidelines for the early management of patients with acute 
ischemic stroke: a guideline for healthcare professionals from the American 
Heart Association/American Stroke Association. Stroke 2013;44(3):870-
947. 
 
19. The Norwegian Directorate of Health. Nasjonal retningslinje for behandling 
og rehabilitering av hjerneslag 2010. Available from: 
http://www.helsedirektoratet.no/publikasjoner/nasjonal-retningslinje-for-
behandling-og-rehabilitering-ved-hjerneslag-fullversjon/Sider/default.aspx. 
Accessed June 2, 2015. 
 
55 
 
20. D'Olhaberriague L, Litvan I, Mitsias P, Mansbach HH. A reappraisal of 
reliability and validity studies in stroke. Stroke 1996;27(12):2331-6. 
 
21. Goldstein LB, Samsa GP. Reliability of the National Institutes of Health 
Stroke Scale. Extension to non-neurologists in the context of a clinical trial. 
Stroke 1997;28(2):307-10. 
 
22. Brott T, Adams HP, Jr., Olinger CP, Marler JR, Barsan WG, Biller J, et al. 
Measurements of acute cerebral infarction: a clinical examination scale. 
Stroke 1989;20(7):864-70. 
 
23. Multicenter trial of hemodilution in ischemic stroke--background and study 
protocol. Scandinavian Stroke Study Group. Stroke 1985;16(5):885-90. 
 
24. Muir KW, Weir CJ, Murray GD, Povey C, Lees KR. Comparison of 
neurological scales and scoring systems for acute stroke prognosis. Stroke 
1996;27(10):1817-20. 
 
25. Mahoney FI, Barthel DW. Functional Evaluation: The Barthel Index. Md 
State Med J 1965;14:61-5. 
 
26. Rankin J. Cerebral vascular accidents in patients over the age of 60. III. 
Diagnosis and treatment. Scott Med J 1957;2(6):254-68. 
 
27. van Swieten JC, Koudstaal PJ, Visser MC, Schouten HJ, van Gijn J. 
Interobserver agreement for the assessment of handicap in stroke patients. 
Stroke 1988;19(5):604-7. 
 
28. Folstein MF, Folstein SE, McHugh PR. "Mini-mental state". A practical 
method for grading the cognitive state of patients for the clinician. J 
Psychiatr Res 1975;12(3):189-98. 
   
29. Molloy DW, Standish TI. A guide to the standardized Mini-Mental State 
Examination. Int Psychogeriatr 1997;9 Suppl 1:87-94; discussion 143-50. 
 
30. Reitan RM. The relation of the trail making test to organic brain damage. J 
Consult Psychol 1955;19(5):393-4. 
 
31. Shulman KI. Clock-drawing: is it the ideal cognitive screening test? Int J 
Geriatr Psychiatry 2000;15(6):548-61. 
 
 
 
56 
 
32. Adams HP, Jr., Bendixen BH, Kappelle LJ, Biller J, Love BB, Gordon DL, 
et al. Classification of subtype of acute ischemic stroke. Definitions for use 
in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke 
Treatment. Stroke 1993;24(1):35-41. 
 
33. Fure B, Wyller TB, Thommessen B. TOAST criteria applied in acute 
ischemic stroke. Acta Neurol Scand 2005;112(4):254-8. 
   
34. Landau WM, Nassief A. Editorial comment -time to burn the TOAST. 
Stroke 2005;36(4):902-4. 
 
35. Jackson C, Sudlow C. Are lacunar strokes really different? A systematic 
review of differences in risk factor profiles between lacunar and nonlacunar 
infarcts. Stroke 2005;36(4):891-901. 
 
36. Amarenco P, Bogousslavsky J, Caplan LR, Donnan GA, Hennerici MG. 
New approach to stroke subtyping: the A-S-C-O (phenotypic) classification 
of stroke. Cerebrovasc Dis 2009;27(5):502-8. 
 
37. Ay H, Benner T, Arsava EM, Furie KL, Singhal AB, Jensen MB, et al. A 
computerized algorithm for etiologic classification of ischemic stroke: the 
Causative Classification of Stroke System. Stroke 2007;38(11):2979-84. 
 
38. Marnane M, Duggan CA, Sheehan OC, Merwick A, Hannon N, Curtin D, et 
al. Stroke subtype classification to mechanism-specific and undetermined 
categories by TOAST, A-S-C-O, and causative classification system: direct 
comparison in the North Dublin population stroke study. Stroke 
2010;41(8):1579-86. 
 
39. Bamford J, Sandercock P, Dennis M, Burn J, Warlow C. Classification and 
natural history of clinically identifiable subtypes of cerebral infarction. 
Lancet 1991;337(8756):1521-6. 
 
40. Lindley RI, Warlow CP, Wardlaw JM, Dennis MS, Slattery J, Sandercock 
PA. Interobserver reliability of a clinical classification of acute cerebral 
infarction. Stroke 1993;24(12):1801-4. 
 
41. Asdaghi N, Jeerakathil T, Hameed B, Saini M, McCombe JA, Shuaib A, et 
al. Oxfordshire community stroke project classification poorly differentiates 
small cortical and subcortical infarcts. Stroke 2011;42(8):2143-8. 
 
42. Wardlaw JM, Lewis SC, Dennis MS, Counsell C, McDowall M. Is visible 
infarction on computed tomography associated with an adverse prognosis in 
acute ischemic stroke? Stroke 1998;29(7):1315-9. 
57 
 
 
43. Allmendinger AM, Tang ER, Lui YW, Spektor V. Imaging of stroke: Part 
1, Perfusion CT -overview of imaging technique, interpretation pearls, and 
common pitfalls. AJR Am J Roentgenol 2012;198(1):52-62. 
 
44. Kidwell CS, Chalela JA, Saver JL, Starkman S, Hill MD, Demchuk AM, et 
al. Comparison of MRI and CT for detection of acute intracerebral 
hemorrhage. JAMA  2004;292(15):1823-30. 
 
45. Brazzelli M, Sandercock PA, Chappell FM, Celani MG, Righetti E, Arestis 
N, et al. Magnetic resonance imaging versus computed tomography for 
detection of acute vascular lesions in patients presenting with stroke 
symptoms. Cochrane Database Syst Rev 2009(4):Cd007424. 
 
46. Lee LJ, Kidwell CS, Alger J, Starkman S, Saver JL. Impact on stroke 
subtype diagnosis of early diffusion-weighted magnetic resonance imaging 
and magnetic resonance angiography. Stroke 2000;31(5):1081-9. 
 
47. Schellinger PD, Bryan RN, Caplan LR, Detre JA, Edelman RR, Jaigobin C, 
et al. Evidence-based guideline: The role of diffusion and perfusion MRI for 
the diagnosis of acute ischemic stroke: report of the Therapeutics and 
Technology Assessment Subcommittee of the American Academy of 
Neurology. Neurology 2010;75(2):177-85. 
 
48. Wardlaw JM, Chappell FM, Best JJ, Wartolowska K, Berry E, Research 
NHS, et al. Non-invasive imaging compared with intra-arterial angiography 
in the diagnosis of symptomatic carotid stenosis: a meta-analysis. Lancet 
2006;367(9521):1503-12. 
 
49. Saqqur M, Tsivgoulis G, Nicoli F, Skoloudik D, Sharma VK, Larrue V, et 
al. The role of sonolysis and sonothrombolysis in acute ischemic stroke: a 
systematic review and meta-analysis of randomized controlled trials and 
case-control studies. J Neuroimaging 2014;24(3):209-20. 
 
50. Gosling RG, King DH. Arterial assessment by Doppler-shift ultrasound. 
Proc R Soc Med 1974;67(6 Pt 1):447-9. 
 
51. Foerstl H, Biedert S, Hewer W. Multiinfarct and Alzheimer-type dementia 
investigated by transcranial Doppler sonography. Biol Psychiatry 
1989;26(6):590-4. 
 
52. Kidwell CS, el-Saden S, Livshits Z, Martin NA, Glenn TC, Saver JL. 
Transcranial Doppler pulsatility indices as a measure of diffuse small-vessel 
disease. J Neuroimaging 2001;11(3):229-35. 
58 
 
 
53. Lee KY, Sohn YH, Baik JS, Kim GW, Kim JS. Arterial pulsatility as an 
index of cerebral microangiopathy in diabetes. Stroke 2000;31(5):1111-5. 
 
54. Mok V, Ding D, Fu J, Xiong Y, Chu WW, Wang D, et al. Transcranial 
Doppler ultrasound for screening cerebral small vessel disease: a 
community study. Stroke 2012;43(10):2791-3. 
 
55. Tegeler CH, Crutchfield K, Katsnelson M, Kim J, Tang R, Passmore Griffin 
L, et al. Transcranial Doppler velocities in a large, healthy population. J 
Neuroimaging 2013;23(3):466-72. 
 
56. de Bruijn SF, Agema WR, Lammers GJ, van der Wall EE, Wolterbeek R, 
Holman ER, et al. Transesophageal echocardiography is superior to 
transthoracic echocardiography in management of patients of any age with 
transient ischemic attack or stroke. Stroke 2006;37(10):2531-4. 
 
57. Goldstein LB, Adams R, Alberts MJ, Appel LJ, Brass LM, Bushnell CD, et 
al. Primary prevention of ischemic stroke: a guideline from the American 
Heart Association/American Stroke Association Stroke Council: 
cosponsored by the Atherosclerotic Peripheral Vascular Disease 
Interdisciplinary Working Group; Cardiovascular Nursing Council; Clinical 
Cardiology Council; Nutrition, Physical Activity, and Metabolism Council; 
and the Quality of Care and Outcomes Research Interdisciplinary Working 
Group. Circulation 2006;113(24):e873-923. 
 
58. Sacco RL. Risk factors, outcomes, and stroke subtypes for ischemic stroke. 
Neurology 1997;49(5 Suppl 4):S39-44. 
 
59. Organised inpatient (stroke unit) care for stroke. Cochrane Database Syst 
2013;9:Cd000197. 
 
60. Indredavik B, Bakke F, Slordahl SA, Rokseth R, Haheim LL. Stroke unit 
treatment. 10-year follow-up. Stroke 1999;30(8):1524-7. 
 
61. Wardlaw JM, Murray V, Berge E, del Zoppo G, Sandercock P, Lindley RL, 
et al. Recombinant tissue plasminogen activator for acute ischaemic stroke: 
an updated systematic review and meta-analysis. Lancet 
2012;379(9834):2364-72. 
 
62. Berkhemer OA, Fransen PS, Beumer D, van den Berg LA, Lingsma HF, 
Yoo AJ, et al. A randomized trial of intraarterial treatment for acute 
ischemic stroke. N Engl J Med 2015;372(1):11-20. 
59 
 
63. Antithrombotic Trialists C. Collaborative meta-analysis of randomised trials 
of antiplatelet therapy for prevention of death, myocardial infarction, and 
stroke in high risk patients. BMJ 2002;324(7329):71-86. 
 
64. Saxena R, Koudstaal P. Anticoagulants versus antiplatelet therapy for 
preventing stroke in patients with nonrheumatic atrial fibrillation and a 
history of stroke or transient ischemic attack. Cochrane Database Syst Rev 
2004(4):Cd000187. 
 
65. Gomez-Outes A, Terleira-Fernandez AI, Calvo-Rojas G, Suarez-Gea ML, 
Vargas-Castrillon E. Dabigatran, Rivaroxaban, or Apixaban versus 
Warfarin in Patients with Nonvalvular Atrial Fibrillation: A Systematic 
Review and Meta-Analysis of Subgroups. Thrombosis 2013;2013:640723. 
 
66. Norrving B. Long-term prognosis after lacunar infarction. Lancet neurology 
2003;2(4):238-45. 
 
67. Mohr JP. Lacunes. Stroke 1982;13(1):3-11. 
 
68. Wardlaw JM, Smith EE, Biessels GJ, Cordonnier C, Fazekas F, Frayne R, et 
al. Neuroimaging standards for research into small vessel disease and its 
contribution to ageing and neurodegeneration. Lancet Neurol 
2013;12(8):822-38. 
 
69. Pantoni L, Garcia JH. Pathogenesis of leukoaraiosis: a review. Stroke 
1997;28(3):652-9. 
 
70. Das RR, Seshadri S, Beiser AS, Kelly-Hayes M, Au R, Himali JJ, et al. 
Prevalence and correlates of silent cerebral infarcts in the Framingham 
offspring study. Stroke 2008;39(11):2929-35. 
 
71. Vermeer SE, Longstreth WT, Jr., Koudstaal PJ. Silent brain infarcts: a 
systematic review. Lancet Neurol 2007;6(7):611-9. 
 
72. Wong TY, Klein R, Sharrett AR, Nieto FJ, Boland LL, Couper DJ, et al. 
Retinal microvascular abnormalities and cognitive impairment in middle-
aged persons: the Atherosclerosis Risk in Communities Study. Stroke 
2002;33(6):1487-92. 
 
73. Patton N, Pattie A, MacGillivray T, Aslam T, Dhillon B, Gow A, et al. The 
association between retinal vascular network geometry and cognitive ability 
in an elderly population. Invest Ophthalmol Vis Sci 2007;48(5):1995-2000. 
 
60 
 
74. Cooper LS, Wong TY, Klein R, Sharrett AR, Bryan RN, Hubbard LD, et al. 
Retinal microvascular abnormalities and MRI-defined subclinical cerebral 
infarction: the Atherosclerosis Risk in Communities Study. Stroke 
2006;37(1):82-6. 
 
75. Martinez-Vea A, Salvado E, Bardaji A, Gutierrez C, Ramos A, Garcia C, et 
al. Silent cerebral white matter lesions and their relationship with vascular 
risk factors in middle-aged predialysis patients with CKD. Am J Kidney Dis 
2006;47(2):241-50. 
 
76. Liew G, Mitchell P, Wong TY, Iyengar SK, Wang JJ. CKD increases the 
risk of age-related macular degeneration. J Am Soc Nephrol 
2008;19(4):806-11. 
 
77. Khatri M, Wright CB, Nickolas TL, Yoshita M, Paik MC, Kranwinkel G, et 
al. Chronic kidney disease is associated with white matter hyperintensity 
volume: the Northern Manhattan Study (NOMAS). Stroke 
2007;38(12):3121-6. 
 
78. Thompson CS, Hakim AM. Living beyond our physiological means: small 
vessel disease of the brain is an expression of a systemic failure in arteriolar 
function: a unifying hypothesis. Stroke 2009;40(5):e322-30. 
 
79. Norrving B. Lacunar infarcts: no black holes in the brain are benign. Pract 
Neurol 2008;8(4):222-8. 
 
80. Fisher CM. Lacunar strokes and infarcts: a review. Neurology 
1982;32(8):871-6. 
 
81. Arboix A, Marti-Vilalta JL. Lacunar stroke. Expert Rev Neurother 
2009;9(2):179-96. 
 
82. Staaf G, Lindgren A, Norrving B. Pure motor stroke from presumed lacunar 
infarct: long-term prognosis for survival and risk of recurrent stroke. Stroke 
2001;32(11):2592-6. 
 
83. Fisher CM. Lacunes: Small, Deep Cerebral Infarcts. Neurology 
1965;15:774-84. 
 
84. Fisher CM. A lacunar stroke. The dysarthria-clumsy hand syndrome. 
Neurology 1967;17(6):614-7. 
 
85. Fisher CM. Thalamic pure sensory stroke: a pathologic study. Neurology 
1978;28(11):1141-4. 
61 
 
86. Aharon-Peretz J, Daskovski E, Mashiach T, Tomer R. Natural history of 
dementia associated with lacunar infarctions. J Neurol Sci 2002;203-
204:53-5. 
 
87. Fure B, Bruun Wyller T, Engedal K, Thommessen B. Cognitive 
impairments in acute lacunar stroke. Acta Neurol Scand 2006;114(1):17-22. 
 
88. Vermeer SE, Prins ND, den Heijer T, Hofman A, Koudstaal PJ, Breteler 
MM. Silent brain infarcts and the risk of dementia and cognitive decline. N 
Engl J Med 2003;348(13):1215-22. 
 
89. Grau-Olivares M, Arboix A, Bartres-Faz D, Junque C. Neuropsychological 
abnormalities associated with lacunar infarction. J Neurol Sci 2007;257(1-
2):160-5. 
 
90. Blanco-Rojas L, Arboix A, Canovas D, Grau-Olivares M, Oliva Morera JC, 
Parra O. Cognitive profile in patients with a first-ever lacunar infarct with 
and without silent lacunes: a comparative study. BMC neurol 2013;13:203. 
 
91. Yamamoto Y, Akiguchi I, Oiwa K, Hayashi M, Kasai T, Ozasa K. Twenty-
four-hour blood pressure and MRI as predictive factors for different 
outcomes in patients with lacunar infarct. Stroke 2002;33(1):297-305. 
 
92. Edwards JD, Jacova C, Sepehry AA, Pratt B, Benavente OR. A quantitative 
systematic review of domain-specific cognitive impairment in lacunar 
stroke. Neurology 2013;80(3):315-22. 
 
93. Jacova C, Pearce LA, Costello R, McClure LA, Holliday SL, Hart RG, et al. 
Cognitive impairment in lacunar strokes: the SPS3 trial. Ann Neurol 
2012;72(3):351-62. 
 
94. Wessels T, Wessels C, Ellsiepen A, Reuter I, Trittmacher S, Stolz E, et al. 
Contribution of diffusion-weighted imaging in determination of stroke 
etiology. AJNR Am J Neuroradiol 2006;27(1):35-9. 
 
95. Ivnik RJ. Neuropsychological tests' norms above age 55: COWAT, BNT, 
MAE token, WRAT-R reading, AMNART, STROOP, TMT, and JLO. 
Clinical Neuropsychol 1996; 10(3):262-78  
 
96. Arboix A, Blanco-Rojas L, Marti-Vilalta JL. Advancements in 
understanding the mechanisms of symptomatic lacunar ischemic stroke: 
translation of knowledge to prevention strategies. Expert Rev Neurother 
2014;14(3):261-76. 
62 
 
97. Boiten J, Lodder J. Lacunar infarcts. Pathogenesis and validity of the 
clinical syndromes. Stroke 1991;22(11):1374-8. 
 
98. Melo TP, Bogousslavsky J, van Melle G, Regli F. Pure motor stroke: a 
reappraisal. Neurology 1992;42(4):789-95. 
 
99. Gan R, Sacco RL, Kargman DE, Roberts JK, Boden-Albala B, Gu Q. 
Testing the validity of the lacunar hypothesis: the Northern Manhattan 
Stroke Study experience. Neurology 1997;48(5):1204-11. 
 
100. Phillips SJ, Dai D, Mitnitski A, Gubitz GJ, Johnston KC, Koroshetz WJ, et 
al. Clinical diagnosis of lacunar stroke in the first 6 hours after symptom 
onset: analysis of data from the glycine antagonist in neuroprotection 
(GAIN) Americas trial. Stroke 2007;38(10):2706-11. 
 
101. Naess H, Brogger JC, Jr., Idicula T, Waje-Andreassen U, Moen G, 
Thomassen L. Clinical presentation and diffusion weighted MRI of acute 
cerebral infarction. The Bergen Stroke Study. BMC Neurol 2009;9:44. 
 
102. Sylaja PN, Coutts SB, Krol A, Hill MD, Demchuk AM. When to expect 
negative diffusion-weighted images in stroke and transient ischemic attack. 
Stroke 2008;39(6):1898-900. 
 
103. Fernandes PM, Whiteley WN, Hart SR, Al-Shahi Salman R. Strokes: 
mimics and chameleons. Pract Neurol 2013;13(1):21-8. 
 
104. Seifert T, Enzinger C, Storch MK, Pichler G, Niederkorn K, Fazekas F. 
Acute small subcortical infarctions on diffusion weighted MRI: clinical 
presentation and aetiology. J Neurol Neurosurg Psychiatry 
2005;76(11):1520-4. 
 
105. Mead GE, Lewis SC, Wardlaw JM, Dennis MS, Warlow CP. Should 
computed tomography appearance of lacunar stroke influence patient 
management? J Neurol Neurosurg Psychiatry 1999;67(5):682-4. 
 
106. Semplicini A, Maresca A, Boscolo G, Sartori M, Rocchi R, Giantin V, et al. 
Hypertension in acute ischemic stroke: a compensatory mechanism or an 
additional damaging factor? Arch Intern Med 2003;163(2):211-6. 
 
107. Toyoda K, Okada Y, Fujimoto S, Hagiwara N, Nakachi K, Kitazono T, et 
al. Blood pressure changes during the initial week after different subtypes of 
ischemic stroke. Stroke 2006;37(10):2637-9. 
 
63 
 
108. Meurer WJ, Sanchez BN, Smith MA, Lisabeth LD, Majersik JJ, Brown DL, 
et al. Predicting ischaemic stroke subtype from presenting systolic blood 
pressure: the BASIC Project. J Intern Med 2009;265(3):388-96. 
 
109. Rodriguez-Garcia JL, Botia E, de La Sierra A, Villanueva MA, Gonzalez-
Spinola J. Significance of elevated blood pressure and its management on 
the short-term outcome of patients with acute ischemic stroke. Am J 
Hypertens 2005;18(3):379-84. 
 
110. Vemmos KN, Tsivgoulis G, Spengos K, Synetos A, Manios E, 
Vassilopoulou S, et al. Blood pressure course in acute ischaemic stroke in 
relation to stroke subtype. Blood Press Monit 2004;9(3):107-14. 
 
111. Ishitsuka K, Kamouchi M, Hata J, Fukuda K, Matsuo R, Kuroda J, et al. 
High blood pressure after acute ischemic stroke is associated with poor 
clinical outcomes: Fukuoka Stroke Registry. Hypertension 2014;63(1):54-
60. 
 
112. Willmot M, Leonardi-Bee J, Bath PM. High blood pressure in acute stroke 
and subsequent outcome: a systematic review. Hypertension 2004;43(1):18-
24. 
 
113. Kvistad CE, Logallo N, Oygarden H, Thomassen L, Waje-Andreassen U, 
Naess H. Elevated Admission Blood Pressure and Stroke Severity in Acute 
Ischemic Stroke: The Bergen NORSTROKE Study. Cerebrovasc Dis 
2013;36(5-6):351-4. 
 
114. Pearce LA, McClure LA, Anderson DC, Jacova C, Sharma M, Hart RG, et 
al. Effects of long-term blood pressure lowering and dual antiplatelet 
treatment on cognitive function in patients with recent lacunar stroke: a 
secondary analysis from the SPS3 randomised trial. Lancet Neurol 
2014;13(12):1177-85. 
 
115. Soros P, Whitehead S, Spence JD, Hachinski V. Antihypertensive treatment 
can prevent stroke and cognitive decline. Nat Rev Neurol 2013;9(3):174-8. 
 
116. Lopez-Oloriz J, Lopez-Cancio E, Arenillas JF, Hernandez M, Dorado L, 
Dacosta-Aguayo R, et al. Diffusion tensor imaging, intracranial vascular 
resistance and cognition in middle-aged asymptomatic subjects. 
Cerebrovasc Dis 2014;38(1):24-30. 
 
 
 
64 
 
117. Sabayan B, Jansen S, Oleksik AM, van Osch MJ, van Buchem MA, van 
Vliet P, et al. Cerebrovascular hemodynamics in Alzheimer's disease and 
vascular dementia: a meta-analysis of transcranial Doppler studies. Ageing 
Res Rev 2012;11(2):271-7. 
 
118. Blake H, McKinney M, Treece K, Lee E, Lincoln NB. An evaluation of 
screening measures for cognitive impairment after stroke. Age Ageing 
2002;31(6):451-6. 
 
119. Benavente OR, White CL, Pearce L, Pergola P, Roldan A, Benavente MF, 
et al. The Secondary Prevention of Small Subcortical Strokes (SPS3) study. 
Int J Stroke 2011;6(2):164-75. 
 
120. Park JS, Cho MH, Lee KY, Kim CS, Kim HJ, Nam JS, et al. Cerebral 
arterial pulsatility and insulin resistance in type 2 diabetic patients. Diabetes 
Res Clin Pract 2008;79(2):237-42. 
 
121. Palacio S, McClure LA, Benavente OR, Bazan C, 3rd, Pergola P, Hart RG. 
Lacunar strokes in patients with diabetes mellitus: risk factors, infarct 
location, and prognosis: the secondary prevention of small subcortical 
strokes study. Stroke 2014;45(9):2689-94. 
 
122. Brazzelli M, Chappell FM, Miranda H, Shuler K, Dennis M, Sandercock 
PA, et al. Diffusion-weighted imaging and diagnosis of transient ischemic 
attack. Ann Neurol 2014;75(1):67-76. 
 
123. Britton M, Carlsson A, de Faire U. Blood pressure course in patients with 
acute stroke and matched controls. Stroke 1986;17(5):861-4. 
 
124. Carlberg B, Asplund K, Hagg E. Factors influencing admission blood 
pressure levels in patients with acute stroke. Stroke 1991;22(4):527-30. 
 
125. Harper G, Castleden CM, Potter JF. Factors affecting changes in blood 
pressure after acute stroke. Stroke 1994;25(9):1726-9. 
 
126. Wallace JD, Levy LL. Blood pressure after stroke. JAMA  
1981;246(19):2177-80. 
 
127. Faiz KW, Sundseth A, Thommessen B, Ronning OM. Prehospital delay in 
acute stroke and TIA. Emerg Med J 2013;30(8):669-74. 
 
128. Agyeman O, Nedeltchev K, Arnold M, Fischer U, Remonda L, Isenegger J, 
et al. Time to admission in acute ischemic stroke and transient ischemic 
attack. Stroke 2006;37(4):963-6. 
65 
 
 
9. ERRATA 
  
66 
 
  
67 
 
10. APPENDIX 
10.1. National Institutes of Health Stroke Scale - Norwegian version 
 
 
68 
 
  
69 
 
10.2. Modified Rankin Scale - Norwegian version 
  
70 
 
10.3. Mini Mental State Examination - Norwegian version 
 
 
71 
 
 
 
 
 
 
72 
 
  
73 
 
10.4. Clock drawing test - Norwegian version 
 
 
 
 
 
 
74 
 
  
75 
 
10.5. Trail Making Test A - Norwegian version 
 
 
 
 
 
 
 
 
76 
 
 
 
 
 
 
77 
 
  
78 
 
10.6. Trail Making Test B - Norwegian version 
 
 
 
 
79 
 
 
 
 
 
80 
 
  
81 
 
10.7. Barthel Activities of Daily Living Index - Norwegian version 
  
82 
 
  
